IBDEI0YG ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,15552,0)
;;=90653^^59^750^13^^^^1
;;^UTILITY(U,$J,358.3,15552,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15552,1,2,0)
;;=2^90653
;;^UTILITY(U,$J,358.3,15552,1,3,0)
;;=3^FLU VACCINE SINGLE DOSE SYR (Fluad)
;;^UTILITY(U,$J,358.3,15553,0)
;;=99452^^59^751^1^^^^1
;;^UTILITY(U,$J,358.3,15553,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15553,1,2,0)
;;=2^99452
;;^UTILITY(U,$J,358.3,15553,1,3,0)
;;=3^E-Consult Results/Discussion with Patient
;;^UTILITY(U,$J,358.3,15554,0)
;;=0001A^^59^752^1^^^^1
;;^UTILITY(U,$J,358.3,15554,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15554,1,2,0)
;;=2^0001A
;;^UTILITY(U,$J,358.3,15554,1,3,0)
;;=3^Admin COVID-19 Vaccine (Moderna),1st Dose
;;^UTILITY(U,$J,358.3,15555,0)
;;=0012A^^59^752^2^^^^1
;;^UTILITY(U,$J,358.3,15555,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15555,1,2,0)
;;=2^0012A
;;^UTILITY(U,$J,358.3,15555,1,3,0)
;;=3^Admin COVID-19 Vaccine (Moderna),2nd Dose
;;^UTILITY(U,$J,358.3,15556,0)
;;=0001A^^59^752^3^^^^1
;;^UTILITY(U,$J,358.3,15556,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15556,1,2,0)
;;=2^0001A
;;^UTILITY(U,$J,358.3,15556,1,3,0)
;;=3^Admin COVID-19 Vaccine (Pfizer),1st Dose
;;^UTILITY(U,$J,358.3,15557,0)
;;=0002A^^59^752^4^^^^1
;;^UTILITY(U,$J,358.3,15557,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15557,1,2,0)
;;=2^0002A
;;^UTILITY(U,$J,358.3,15557,1,3,0)
;;=3^Admin COVID-19 Vaccine (Pfizer),2nd Dose
;;^UTILITY(U,$J,358.3,15558,0)
;;=Q0243^^59^752^7^^^^1
;;^UTILITY(U,$J,358.3,15558,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15558,1,2,0)
;;=2^Q0243
;;^UTILITY(U,$J,358.3,15558,1,3,0)
;;=3^Casirivimab & Imdevimab 2400mg
;;^UTILITY(U,$J,358.3,15559,0)
;;=M0243^^59^752^8^^^^1
;;^UTILITY(U,$J,358.3,15559,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15559,1,2,0)
;;=2^M0243
;;^UTILITY(U,$J,358.3,15559,1,3,0)
;;=3^Casirivimab & Imdevimab Infusion
;;^UTILITY(U,$J,358.3,15560,0)
;;=91300^^59^752^9^^^^1
;;^UTILITY(U,$J,358.3,15560,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15560,1,2,0)
;;=2^91300
;;^UTILITY(U,$J,358.3,15560,1,3,0)
;;=3^SARSCOV2 Vaccine 0.3ml (Pfizer)
;;^UTILITY(U,$J,358.3,15561,0)
;;=91301^^59^752^10^^^^1
;;^UTILITY(U,$J,358.3,15561,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15561,1,2,0)
;;=2^91301
;;^UTILITY(U,$J,358.3,15561,1,3,0)
;;=3^SARSCOV2 Vaccine 0.5ml (Moderna)
;;^UTILITY(U,$J,358.3,15562,0)
;;=M0245^^59^752^5^^^^1
;;^UTILITY(U,$J,358.3,15562,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15562,1,2,0)
;;=2^M0245
;;^UTILITY(U,$J,358.3,15562,1,3,0)
;;=3^Bamlanivimab Infusion w/ Post Admin Monitoring
;;^UTILITY(U,$J,358.3,15563,0)
;;=Q0245^^59^752^6^^^^1
;;^UTILITY(U,$J,358.3,15563,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15563,1,2,0)
;;=2^Q0245
;;^UTILITY(U,$J,358.3,15563,1,3,0)
;;=3^Bamlanivivab 700mg
;;^UTILITY(U,$J,358.3,15564,0)
;;=99424^^59^753^1^^^^1
;;^UTILITY(U,$J,358.3,15564,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15564,1,2,0)
;;=2^99424
;;^UTILITY(U,$J,358.3,15564,1,3,0)
;;=3^Prin Care Mgmt,Phys,1st 30 min,per Clndr Mnth
;;^UTILITY(U,$J,358.3,15565,0)
;;=99425^^59^753^2^^^^1
;;^UTILITY(U,$J,358.3,15565,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,15565,1,2,0)
;;=2^99425
;;^UTILITY(U,$J,358.3,15565,1,3,0)
;;=3^Prin Care Mgmt,Phys,Ea Addl 30 min,per Clndr Mnth
;;^UTILITY(U,$J,358.3,15566,0)
;;=99426^^59^753^3^^^^1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0YG 3792 printed Nov 22, 2024@17:08:25 Page 2
IBDEI0YG ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,15552,0)
+2 ;;=90653^^59^750^13^^^^1
+3 ;;^UTILITY(U,$J,358.3,15552,1,0)
+4 ;;=^358.31IA^3^2
+5 ;;^UTILITY(U,$J,358.3,15552,1,2,0)
+6 ;;=2^90653
+7 ;;^UTILITY(U,$J,358.3,15552,1,3,0)
+8 ;;=3^FLU VACCINE SINGLE DOSE SYR (Fluad)
+9 ;;^UTILITY(U,$J,358.3,15553,0)
+10 ;;=99452^^59^751^1^^^^1
+11 ;;^UTILITY(U,$J,358.3,15553,1,0)
+12 ;;=^358.31IA^3^2
+13 ;;^UTILITY(U,$J,358.3,15553,1,2,0)
+14 ;;=2^99452
+15 ;;^UTILITY(U,$J,358.3,15553,1,3,0)
+16 ;;=3^E-Consult Results/Discussion with Patient
+17 ;;^UTILITY(U,$J,358.3,15554,0)
+18 ;;=0001A^^59^752^1^^^^1
+19 ;;^UTILITY(U,$J,358.3,15554,1,0)
+20 ;;=^358.31IA^3^2
+21 ;;^UTILITY(U,$J,358.3,15554,1,2,0)
+22 ;;=2^0001A
+23 ;;^UTILITY(U,$J,358.3,15554,1,3,0)
+24 ;;=3^Admin COVID-19 Vaccine (Moderna),1st Dose
+25 ;;^UTILITY(U,$J,358.3,15555,0)
+26 ;;=0012A^^59^752^2^^^^1
+27 ;;^UTILITY(U,$J,358.3,15555,1,0)
+28 ;;=^358.31IA^3^2
+29 ;;^UTILITY(U,$J,358.3,15555,1,2,0)
+30 ;;=2^0012A
+31 ;;^UTILITY(U,$J,358.3,15555,1,3,0)
+32 ;;=3^Admin COVID-19 Vaccine (Moderna),2nd Dose
+33 ;;^UTILITY(U,$J,358.3,15556,0)
+34 ;;=0001A^^59^752^3^^^^1
+35 ;;^UTILITY(U,$J,358.3,15556,1,0)
+36 ;;=^358.31IA^3^2
+37 ;;^UTILITY(U,$J,358.3,15556,1,2,0)
+38 ;;=2^0001A
+39 ;;^UTILITY(U,$J,358.3,15556,1,3,0)
+40 ;;=3^Admin COVID-19 Vaccine (Pfizer),1st Dose
+41 ;;^UTILITY(U,$J,358.3,15557,0)
+42 ;;=0002A^^59^752^4^^^^1
+43 ;;^UTILITY(U,$J,358.3,15557,1,0)
+44 ;;=^358.31IA^3^2
+45 ;;^UTILITY(U,$J,358.3,15557,1,2,0)
+46 ;;=2^0002A
+47 ;;^UTILITY(U,$J,358.3,15557,1,3,0)
+48 ;;=3^Admin COVID-19 Vaccine (Pfizer),2nd Dose
+49 ;;^UTILITY(U,$J,358.3,15558,0)
+50 ;;=Q0243^^59^752^7^^^^1
+51 ;;^UTILITY(U,$J,358.3,15558,1,0)
+52 ;;=^358.31IA^3^2
+53 ;;^UTILITY(U,$J,358.3,15558,1,2,0)
+54 ;;=2^Q0243
+55 ;;^UTILITY(U,$J,358.3,15558,1,3,0)
+56 ;;=3^Casirivimab & Imdevimab 2400mg
+57 ;;^UTILITY(U,$J,358.3,15559,0)
+58 ;;=M0243^^59^752^8^^^^1
+59 ;;^UTILITY(U,$J,358.3,15559,1,0)
+60 ;;=^358.31IA^3^2
+61 ;;^UTILITY(U,$J,358.3,15559,1,2,0)
+62 ;;=2^M0243
+63 ;;^UTILITY(U,$J,358.3,15559,1,3,0)
+64 ;;=3^Casirivimab & Imdevimab Infusion
+65 ;;^UTILITY(U,$J,358.3,15560,0)
+66 ;;=91300^^59^752^9^^^^1
+67 ;;^UTILITY(U,$J,358.3,15560,1,0)
+68 ;;=^358.31IA^3^2
+69 ;;^UTILITY(U,$J,358.3,15560,1,2,0)
+70 ;;=2^91300
+71 ;;^UTILITY(U,$J,358.3,15560,1,3,0)
+72 ;;=3^SARSCOV2 Vaccine 0.3ml (Pfizer)
+73 ;;^UTILITY(U,$J,358.3,15561,0)
+74 ;;=91301^^59^752^10^^^^1
+75 ;;^UTILITY(U,$J,358.3,15561,1,0)
+76 ;;=^358.31IA^3^2
+77 ;;^UTILITY(U,$J,358.3,15561,1,2,0)
+78 ;;=2^91301
+79 ;;^UTILITY(U,$J,358.3,15561,1,3,0)
+80 ;;=3^SARSCOV2 Vaccine 0.5ml (Moderna)
+81 ;;^UTILITY(U,$J,358.3,15562,0)
+82 ;;=M0245^^59^752^5^^^^1
+83 ;;^UTILITY(U,$J,358.3,15562,1,0)
+84 ;;=^358.31IA^3^2
+85 ;;^UTILITY(U,$J,358.3,15562,1,2,0)
+86 ;;=2^M0245
+87 ;;^UTILITY(U,$J,358.3,15562,1,3,0)
+88 ;;=3^Bamlanivimab Infusion w/ Post Admin Monitoring
+89 ;;^UTILITY(U,$J,358.3,15563,0)
+90 ;;=Q0245^^59^752^6^^^^1
+91 ;;^UTILITY(U,$J,358.3,15563,1,0)
+92 ;;=^358.31IA^3^2
+93 ;;^UTILITY(U,$J,358.3,15563,1,2,0)
+94 ;;=2^Q0245
+95 ;;^UTILITY(U,$J,358.3,15563,1,3,0)
+96 ;;=3^Bamlanivivab 700mg
+97 ;;^UTILITY(U,$J,358.3,15564,0)
+98 ;;=99424^^59^753^1^^^^1
+99 ;;^UTILITY(U,$J,358.3,15564,1,0)
+100 ;;=^358.31IA^3^2
+101 ;;^UTILITY(U,$J,358.3,15564,1,2,0)
+102 ;;=2^99424
+103 ;;^UTILITY(U,$J,358.3,15564,1,3,0)
+104 ;;=3^Prin Care Mgmt,Phys,1st 30 min,per Clndr Mnth
+105 ;;^UTILITY(U,$J,358.3,15565,0)
+106 ;;=99425^^59^753^2^^^^1
+107 ;;^UTILITY(U,$J,358.3,15565,1,0)
+108 ;;=^358.31IA^3^2
+109 ;;^UTILITY(U,$J,358.3,15565,1,2,0)
+110 ;;=2^99425
+111 ;;^UTILITY(U,$J,358.3,15565,1,3,0)
+112 ;;=3^Prin Care Mgmt,Phys,Ea Addl 30 min,per Clndr Mnth
+113 ;;^UTILITY(U,$J,358.3,15566,0)
+114 ;;=99426^^59^753^3^^^^1
